Sofinnova Partners
Overview
Sofinnova Partners is a European venture capital firm specializing in Life Sciences. The firm focuses on paradigm shifting technologies alongside visionary entrepreneurs. Sofinnova Partners seeks to invest as a founding and lead investor in start-ups and corporate spin-offs. Medicine and biotech.
Investment Focus
- Innovative life sciences companies
- Strong scientific and business expertise
- Potential for positive impact on healthcare and sustainability
Portfolio Companies
Reach Sofinnova Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Sofinnova Partners
What sectors does Sofinnova Partners invest in?
Sofinnova Partners invests in Healthcare, Sustainability, Medtech, Biotechnology, Industrial Biotech and Digital Medicine, and is based in Paris, Île-De-France, France. Sofinnova Partners is listed as a vc in the ConnectSafely investor database.
What stage does Sofinnova Partners invest at?
Sofinnova Partners backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of $100K - $500K.
Which regions does Sofinnova Partners invest in?
Sofinnova Partners invests across United States, United Kingdom, France and Italy.
What companies has Sofinnova Partners invested in?
Sofinnova Partners's portfolio includes Genentech, Preglem, Movetis, Vistaprint, Fovea, Actelion, CoreValve and Novexel.
How do I contact Sofinnova Partners?
Sofinnova Partners's contact details — including work email, phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
